These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36794167)

  • 21. Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2.
    Machitani M; Takei J; Kaneko MK; Ueki S; Ohashi H; Watashi K; Kato Y; Masutomi K
    Virol J; 2022 Dec; 19(1):213. PubMed ID: 36496472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Denovo designing, retro-combinatorial synthesis, and molecular dynamics analysis identify novel antiviral VTRM1.1 against RNA-dependent RNA polymerase of SARS CoV2 virus.
    Tiwari V
    Int J Biol Macromol; 2021 Feb; 171():358-365. PubMed ID: 33421473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
    Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M
    Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein-protein interaction of RdRp with its co-factor NSP8 and NSP7 to decipher the interface hotspot residues for drug targeting: A comparison between SARS-CoV-2 and SARS-CoV.
    Sarma H; Jamir E; Sastry GN
    J Mol Struct; 2022 Jun; 1257():132602. PubMed ID: 35153334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic conservation of SARS-CoV-2 RNA replication complex in globally circulating isolates and recently emerged variants from humans and minks suggests minimal pre-existing resistance to remdesivir.
    Martin R; Li J; Parvangada A; Perry J; Cihlar T; Mo H; Porter D; Svarovskaia E
    Antiviral Res; 2021 Apr; 188():105033. PubMed ID: 33549572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight.
    Begum F; Srivastava AK; Ray U
    Biochem Biophys Res Commun; 2021 Sep; 571():26-31. PubMed ID: 34303192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of replicating SARS-CoV-2 polymerase.
    Hillen HS; Kokic G; Farnung L; Dienemann C; Tegunov D; Cramer P
    Nature; 2020 Aug; 584(7819):154-156. PubMed ID: 32438371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential Candidates against COVID-19 Targeting RNA-Dependent RNA Polymerase: A Comprehensive Review.
    Agrawal N; Goyal A
    Curr Pharm Biotechnol; 2022; 23(3):396-419. PubMed ID: 33882805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure of the RNA-dependent RNA polymerase from COVID-19 virus.
    Gao Y; Yan L; Huang Y; Liu F; Zhao Y; Cao L; Wang T; Sun Q; Ming Z; Zhang L; Ge J; Zheng L; Zhang Y; Wang H; Zhu Y; Zhu C; Hu T; Hua T; Zhang B; Yang X; Li J; Yang H; Liu Z; Xu W; Guddat LW; Wang Q; Lou Z; Rao Z
    Science; 2020 May; 368(6492):779-782. PubMed ID: 32277040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors.
    Zhao J; Zhang G; Zhang Y; Yi D; Li Q; Ma L; Guo S; Li X; Guo F; Lin R; Luu G; Liu Z; Wang Y; Cen S
    Antiviral Res; 2021 Dec; 196():105209. PubMed ID: 34801588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An efficient computational protocol for template-based design of peptides that inhibit interactions involving SARS-CoV-2 proteins.
    Chenna A; Khan WH; Dash R; Saraswat S; Chugh A; Rathore AS; Goel G
    Proteins; 2023 Sep; 91(9):1222-1234. PubMed ID: 37283297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virtual Screening and Quantum Chemistry Analysis for SARS-CoV-2 RNA-Dependent RNA Polymerase Using the ChEMBL Database: Reproduction of the Remdesivir-RTP and Favipiravir-RTP Binding Modes Obtained from Cryo-EM Experiments with High Binding Affinity.
    Tsuji M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allosteric Activation of SARS-CoV-2 RNA-Dependent RNA Polymerase by Remdesivir Triphosphate and Other Phosphorylated Nucleotides.
    Wang B; Svetlov V; Wolf YI; Koonin EV; Nudler E; Artsimovitch I
    mBio; 2021 Jun; 12(3):e0142321. PubMed ID: 34154407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimized Recombinant Expression and Purification of the SARS-CoV-2 Polymerase Complex.
    Podadera A; Campo L; Rehman F; Kolobaric N; Zutic A; Ng KK
    Curr Protoc; 2024 Mar; 4(3):e1007. PubMed ID: 38511495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
    Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transient SARS-CoV-2 RNA-Dependent RNA Polymerase Mutations after Remdesivir Treatment for Chronic COVID-19 in Two Transplant Recipients: Case Report and Intra-Host Viral Genomic Investigation.
    Yang S; Multani A; Garrigues JM; Oh MS; Hemarajata P; Burleson T; Green NM; Oliai C; Gaynor PT; Beaird OE; Winston DJ; Seet CS; Schaenman JM
    Microorganisms; 2023 Aug; 11(8):. PubMed ID: 37630656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral Drug Discovery for the Treatment of COVID-19 Infections.
    Ng TI; Correia I; Seagal J; DeGoey DA; Schrimpf MR; Hardee DJ; Noey EL; Kati WM
    Viruses; 2022 May; 14(5):. PubMed ID: 35632703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase.
    Zhang L; Zhou R
    J Phys Chem B; 2020 Aug; 124(32):6955-6962. PubMed ID: 32521159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities.
    Subissi L; Posthuma CC; Collet A; Zevenhoven-Dobbe JC; Gorbalenya AE; Decroly E; Snijder EJ; Canard B; Imbert I
    Proc Natl Acad Sci U S A; 2014 Sep; 111(37):E3900-9. PubMed ID: 25197083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient and stabilized complexes of Nsp7, Nsp8, and Nsp12 in SARS-CoV-2 replication.
    Wilamowski M; Hammel M; Leite W; Zhang Q; Kim Y; Weiss KL; Jedrzejczak R; Rosenberg DJ; Fan Y; Wower J; Bierma JC; Sarker AH; Tsutakawa SE; Pingali SV; O'Neill HM; Joachimiak A; Hura GL
    Biophys J; 2021 Aug; 120(15):3152-3165. PubMed ID: 34197805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.